Jubilant Biosys Ltd (JBL) offers end-to-end CRDMO solutions in Structural Biology, Computational Chemistry, Medicinal & Synthetic Chemistry, in-vitro and in-vivo Biology, DMPK, Toxicology, Process R&D & Manufacturing to various Biotech & Pharma companies pursuing drug discovery, development and manufacturing. Jubilant Biosys Limited (JBL) is a subsidiary of Jubilant Pharmova, serving the global life sciences, agrochemicals and specialty chemicals industry through its research centers & manufacturing facilities in India. Jubilant’s services in discovery research include; Jubilant’s services in discovery research includes; • Target Identification/Target Validation to Lead Optimization/ Preclinical candidate, for multiple therapeutic areas viz; Oncology, Metabolic Disorders, CNS, Pain and Inflammation. • Functional services comprising of computational chemistry/ molecular modeling, medicinal chemistry, synthetic chemistry, scale-up (Non-GMP & GMP), structural biology, ADME-PK,in-vitro and in-vivo biology and IND enabling GLP toxicology.
View Top Employees from Jubilant Biosys LimitedLooking for a particular Jubilant Biosys Limited employee's phone or email?
The Jubilant Biosys Limited annual revenue was $50.3 million in 2024.
Giuliano Perfetti is the CEO of Jubilant Biosys Limited.
1,164 people are employed at Jubilant Biosys Limited.
Jubilant Biosys Limited is based in Noida, Uttar Pradesh.
The NAICS codes for Jubilant Biosys Limited are [541711, 32, 541, 325, 54171, 54, 5417].
The SIC codes for Jubilant Biosys Limited are [283, 87, 28, 80, 873].